Stablepharma

Stablepharma cover
1 Queen Square, Bath, BA1 2HA, UK
www.stablepharma.com

Facebook icon Twitter icon LinkedIn icon Instagram icon
The Stablevax process that treats existing vaccines puts them into the injection syringe itself in a thermo stable state until the point of injection. Whilst in the 'dried state' they do not degrade at all. Whereas circa 50% of the world's existing vaccines currently do. Stablevax technology was developed in response to a specific request from WHO for a stabilisation technology that fitted in with existing vaccination practice and which made the injection process simpler and safer.
Business Highlights
lock
Video
lock
Investment Deck
lock
Team
lock

03Other opportunities

SFC Angel Fund XIII SEIS

SFC Angel Fund XIII SEIS

Invest under SEIS in high potential start-ups.
Fund Size £50m SEIS
SFC Angel Fund XI EIS

SFC Angel Fund XI EIS

Invest in SFC’s portfolio stars.
Fund Size £20m EIS

Weedingtech

The most commercially viable alternative to traditional chemical we ...
Raising TBD SEIS/EIS

Sapien Health

Remote health coaching for patients undergoing surgery.
Raising TBD EIS